AIM: To compare the therapeutic efficacy of calcipotriol-PUVA therapy and P
UVA in Korean patients with psoriasis,
METHODS: A total of 38 patients were treated with conventional PUVA and 37
with calcipotriol-PUVA. A comparison was made between the total number of P
UVA treatments and the total UVA dose required to reach clearance in the tw
o groups. Thereafter, categorization into clearing, improvement and failure
was undertaken, with measurement of the psoriasis area and severity index
made at each visit.
RESULTS: Cumulative UVA dose as well as the number and duration of treatmen
ts in the calcipotriol-PUVA group were significantly lower than in the PUVA
-treated group. Some 86% of patients treated with calcipotriol-PUVA showed
clearing compared with 66% calcipotriol-PUVA showed of those treated by PUV
A, In the calcipotriol-PUVA group, the patients with only moderate extent r
equired fewer irradiation treatments, shorter durations of treatment, and a
lower final and cumulative UVA dose to reach clearance than the severely a
ffected group.
CONCLUSION: Combining PUVA with calcipotriol in the treatment of psoriasis
may reduce the risks of long-term UV radiation and improve the clinical res
ponse.